Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/30/2026

1. LFTO
2. CMCSA
3. QNT
4. VRDN
5. NVDA
6. INIO
7. HONA
8. ABBV
9. HON
10. SPY

Go back to Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors
(NASDAQ: BNTC) Delayed: 12.70 +0.33 (2.67%)
Previous Close $12.37    52 Week High $5.64 
Open $12.32    52 Week Low $1.20 
Day High $12.74    P/E N/A 
Day Low $12.04    EPS $0.00 
Volume 98,464